Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board

Overview of attention for article published in Targeted Oncology, February 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

So far, Altmetric has seen 11 X posts from 10 X users, with an upper bound of 47,114 followers.

RT @BenWestphalen: 1/2 🎯 treatment options in #PancreaticCancer are scarce - Still, we have decided to include all #patients in our #Precis…

RT @BenWestphalen: 1/2 🎯 treatment options in #PancreaticCancer are scarce - Still, we have decided to include all #patients in our #Precis…

RT @DerekAOReilly: Excellent paper, emphasising the real-world challenges in implementing #PrecisionMedicine in #PancreaticCancer.

RT @BenWestphalen: 1/2 🎯 treatment options in #PancreaticCancer are scarce - Still, we have decided to include all #patients in our #Precis…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.